General MedicationsTOPICALGeneric
SOLAGE
MEQUINOL; TRETINOIN
Standard Dose
2%;0.01%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview SOLAGE is listed in Drugs@FDA under application 020922 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MEQUINOL; TRETINOIN Form and strength SOLUTION;TOPICAL - 2%;0.01% Sponsor ALMIRALL Submission history Latest submission status date: 2019-12-02 00:00:00.
Structured Monograph
Clinical summary
Approval overview SOLAGE is listed in Drugs@FDA under application 020922 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MEQUINOL; TRETINOIN Form and strength SOLUTION;TOPICAL - 2%;0.01% Sponsor ALMIRALL Submission history Latest submission status date: 2019-12-02 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.